A. T. ÜNALAN Et Al. , "Molecular Docking and in-silico ADMET Studies of Newly Designed Pyrrolo[2,3-d]pyrimidine Derivatives to Inhibit Janus Kinases (JAK1/JAK2)," 11. International Drug Chemistry Conference , Antalya, Turkey, 2023
ÜNALAN, A. T. Et Al. 2023. Molecular Docking and in-silico ADMET Studies of Newly Designed Pyrrolo[2,3-d]pyrimidine Derivatives to Inhibit Janus Kinases (JAK1/JAK2). 11. International Drug Chemistry Conference , (Antalya, Turkey).
ÜNALAN, A. T., NALÇAKAN, H., KURTAY, G., & SEVİN DÜZ, F., (2023). Molecular Docking and in-silico ADMET Studies of Newly Designed Pyrrolo[2,3-d]pyrimidine Derivatives to Inhibit Janus Kinases (JAK1/JAK2) . 11. International Drug Chemistry Conference, Antalya, Turkey
ÜNALAN, ALİ Et Al. "Molecular Docking and in-silico ADMET Studies of Newly Designed Pyrrolo[2,3-d]pyrimidine Derivatives to Inhibit Janus Kinases (JAK1/JAK2)," 11. International Drug Chemistry Conference, Antalya, Turkey, 2023
ÜNALAN, ALİ T. Et Al. "Molecular Docking and in-silico ADMET Studies of Newly Designed Pyrrolo[2,3-d]pyrimidine Derivatives to Inhibit Janus Kinases (JAK1/JAK2)." 11. International Drug Chemistry Conference , Antalya, Turkey, 2023
ÜNALAN, A. T. Et Al. (2023) . "Molecular Docking and in-silico ADMET Studies of Newly Designed Pyrrolo[2,3-d]pyrimidine Derivatives to Inhibit Janus Kinases (JAK1/JAK2)." 11. International Drug Chemistry Conference , Antalya, Turkey.
@conferencepaper{conferencepaper, author={ALİ TOLGA ÜNALAN Et Al. }, title={Molecular Docking and in-silico ADMET Studies of Newly Designed Pyrrolo[2,3-d]pyrimidine Derivatives to Inhibit Janus Kinases (JAK1/JAK2)}, congress name={11. International Drug Chemistry Conference}, city={Antalya}, country={Turkey}, year={2023}}